| SKU | CT-69 |
| Color | Luscious Blackberry |
Overview: Erleada 60 mg (Apalutamide)
Erleada 60 mg, containing the active ingredient Apalutamide, is a specialized oncology medication developed by Janssen. It is classified as an androgen receptor inhibitor, scientifically engineered to interfere with the signaling pathways that allow specific types of hormone-sensitive cancer cells to grow.
Mechanism and Clinical Utility
Erleada functions by binding to the androgen receptor, thereby preventing androgen-mediated tumor cell growth. By inhibiting this pathway, Erleada effectively suppresses the proliferation of tumor cells. This targeted approach is essential for patients managing specific malignancies.
Key Therapeutic Benefits
- Androgen Receptor Inhibition: Highly specific action that targets the androgen signaling pathway to control tumor growth.
- Advanced Oncology Support: Designed as a targeted therapy, offering a precise approach to managing malignancies.
- Clinical Reliability: Developed by Janssen, a global leader in medical research, ensuring high standards of therapeutic efficacy.
- Precise Dosing: Provided as 60 mg film-coated tablets, allowing for accurate administration according to oncologist recommendations.
Product Details and Usage
Erleada 60 mg is provided in a 120-tablet pack, as indicated in "image_c05197.png". This presentation is designed to support the specific dosing schedules required for effective long-term oncology management.
Safety and Storage Guidelines
Administration: Must be taken strictly as prescribed by your oncologist. Read the package insert before use. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the tablets in their original packaging in a cool, dry place (below 30°C) to protect from light and moisture. Keep out of reach of children and do not discard the desiccant.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.
Disclaimer: Erleada is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.
